Related Experiment Video
Updated: May 13, 2025

10:16
Production and Targeting of Monovalent Quantum Dots
Published on: October 23, 2014
25.4K
Stimuli-Responsive Prodrug Linkers That Simultaneously Release Cargo and Neutralize In Situ Generated (Aza)Quinone
Veera V Shivaji R Edupuganti1, Siddharth S Matikonda1, Aggie Lawer1
1School of Pharmacy, University of Otago, 18 Frederick Street, Dunedin, 9054, New Zealand.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|April 16, 2025
Summary
This study introduces a novel prodrug strategy using self-immolative linkers that quench toxic byproducts. The new approach enhances safety and broadens applications for prodrugs and antibody-drug conjugates.
Area of Science:
- Medicinal Chemistry
- Organic Chemistry
- Chemical Biology
Background:
- Self-immolative linkers, such as p-amino/hydroxy-benzyloxycarbonyl (PABC/PHBC) spacers, are crucial in prodrug design.
- A major limitation is the generation of reactive (aza)quinone methide byproducts, posing potential toxicity risks.
Purpose of the Study:
- To develop a novel tripartite prodrug strategy that integrates a self-quenching mechanism for (aza)quinone methide byproducts.
- To create prodrugs with tunable triggers and a PABC/PHBC-type self-immolative spacer containing an integrated nucleophile.
Main Methods:
- Synthesis of novel tripartite prodrugs with diverse triggers (nitro, amide, azide, boronate) and a nucleophile-integrated self-immolative spacer.
- Activation of prodrugs via reductive, hydrolytic, or oxidative stimuli.
- Analysis of the self-quenching mechanism and the resulting tetrahydroisoquinolines (THIQs).
Main Results:
- The integrated nucleophile effectively quenched the reactive (aza)quinone methide, forming stable tetrahydroisoquinolines (THIQs).
- One synthesized THIQ derivative showed no anti-proliferative effects on the A431 mammalian tumor cell line.
- The prodrug strategy demonstrated broad scope, accommodating various triggers and drug/cargo attachments.
Conclusions:
- This new prodrug strategy provides a method to mitigate the toxicity associated with (aza)quinone methide intermediates in self-immolative systems.
- The approach offers versatility in designing prodrugs and antibody-drug conjugates by allowing trigger-specific activation and diverse cargo conjugation.
- The developed linker strategy represents a significant advancement for chemical biology probes and therapeutic delivery systems.

